Skip to main content
Pure Biologics S.A. logo

Pure Biologics S.A. — Investor Relations & Filings

Ticker · PUR ISIN · PLPRBLG00010 LEI · 2594002TXS19AUYHIF82 WAR Manufacturing
Open in API
Filings indexed 515 across all filing types
Latest filing 2024-02-29 Management Reports
Country PL Poland
Listing WAR PUR

About Pure Biologics S.A.

https://purebiologics.com/

Pure Biologics S.A. is a biopharmaceutical company engaged in the discovery and development of novel biological drugs and non-systemic therapies. The company leverages its expertise in antibody and aptamer technologies to create innovative treatments. Its therapeutic portfolio is primarily focused on immuno-oncology. A key aspect of its strategy is the development of original, non-generic and non-biosimilar, biological drug candidates.

Recent filings

Filing Released Lang Actions
Plany Restrukturyzacji Kosztowej Grupy Pure Biologics S.A. - Content (PL)
Management Reports Classification · 99% confidence The document is a short announcement (1303 characters) from the Management Board of Pure Biologics S.A. It details a strategic decision to implement a Cost Restructuring Plan aimed at achieving financial stability by shifting to a 'Virtual Biotech' model, significantly cutting fixed operational costs (over 20 million PLN annually), and selling laboratory assets. The final sentence states, "Szczegóły Planu w załączeniu do niniejszego raportu" (Details of the Plan are attached to this report). According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement that refers to an attached or linked detailed report is classified as a Report Publication Announcement (RPA). This document announces the plan and points to the details, rather than being the detailed plan itself. It is not a standard 10-K, ER, or IR.
2024-02-29 Polish
Projekty uchwał NWZ Pure Biologics S.A._18.03.2024
AGM Information Classification · 98% confidence The document text is titled 'Nadzwyczajnego Walnego Zgromadzenia' (Extraordinary General Meeting) and details resolutions passed during this meeting, specifically concerning the election of the Chairman, adoption of the agenda, and crucially, a resolution to increase the share capital ('podwyższenia kapitału zakładowego') through the issuance of new Series I shares, excluding pre-emptive rights. The content is a formal record of decisions made at a shareholder meeting, including the rationale for capital changes. This strongly aligns with the purpose of an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM) documentation. Since the definition for AGM-R covers 'Presentations and materials shared during the Annual General Meeting (AGM)', and this document details resolutions from an Extraordinary General Meeting (NWZ), AGM-R is the most appropriate classification, as EGMs are functionally similar to AGMs in terms of material type.
2024-02-20 Polish
Ogłoszenie o zwołaniu NWZ Pure Biologics S.A._18.03.2024
AGM Information Classification · 100% confidence The document is titled "OGŁOSZENIE ZARZĄDU PURE BIOLOGICS S.A. Z SIEDZIBĄ WE WROCŁAWIU O ZWOŁANIU NADZWYCZAJNEGO WALNEGO ZGROMADZENIA SPÓŁKI" (Announcement of the Management Board of Pure Biologics S.A. regarding the convening of an Extraordinary General Meeting of the Company). It details the date, time, location, and agenda for an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie). This content directly relates to the formal procedures and materials associated with a shareholder meeting, specifically the notice of convening it. This aligns perfectly with the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (or Extraordinary General Meeting, as the context implies related materials). Although it is a notice to convene, the detailed agenda and procedural rules provided make it more specific than a general Report Publication Announcement (RPA).
2024-02-20 Polish
Informacja o zwołaniu Nadzwyczajnego Walnego Zgromadzenia Pure Biologics S.A. wraz z treścią projektów uchwał - Content (PL)
AGM Information Classification · 98% confidence The document explicitly announces the convening of an 'Nadzwyczajne Walne Zgromadzenie Spółki' (Extraordinary General Meeting of the Company) on March 18, 2024. It details the agenda, which includes resolutions regarding capital increase and changes to the company's articles of association. The text also mentions that the materials (draft resolutions) are attached or available online. This content—announcing the meeting, providing the agenda, and attaching related documents—is characteristic of materials prepared for a shareholder meeting, specifically an Extraordinary General Meeting (EGM). Since the definitions include 'AGM Information (Code: AGM-R)' for Annual General Meeting materials, and this is an Extraordinary General Meeting, the closest fit among the provided codes that relates to general shareholder meetings is AGM-R, as it covers meeting materials. The document is an announcement/notice about the meeting and its contents, not the final voting results (DVA) or a proxy statement (PSI), but rather the preparatory information for the meeting itself.
2024-02-20 Polish
Lista akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym Zgromadzeniu Pure Biologics S.A. 19 lutego 2024 r. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states it is providing a 'wykaz akcjonariuszy Emitenta posiadających co najmniej 5% liczby głosów na Nadzwyczajnym Walnym Zgromadzeniu Spółki' (list of shareholders holding at least 5% of the votes at the Extraordinary General Meeting) held on February 19, 2024. This content directly relates to the results of a shareholder vote at a general meeting, detailing who voted and how many votes they controlled. This aligns perfectly with the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2024-02-20 Polish
Treść uchwał NWZ Pure Biologics S.A._19.02.2024
AGM Information Classification · 99% confidence The document is explicitly titled "PROTOKÓŁ NADZWYCZAJNEGO WALNEGO ZGROMADZENIA" (Minutes of the Extraordinary General Meeting) and details the proceedings, agenda items (including voting on capital increase and loan agreements), and resolutions passed during a meeting held on February 19, 2024. This content directly corresponds to the documentation generated from a General Meeting. Since the document is the full minutes/protocol and not just an announcement about a meeting or a vote result summary, the most appropriate classification is AGM-R (AGM Information), as Extraordinary General Meetings (EGM) fall under the scope of general meeting materials.
2024-02-20 Polish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.